Who are levocarnitine propionate's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Carnitor, CARNITINE, L-carnitine, L-Ornithine.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/levocarnitine-propionate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

levocarnitine propionate — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

levocarnitine propionate (levocarnitine propionate) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Carnitine Analog. Area: Gastroenterology.

unknown Carnitine Analog Gastroenterology Live · refreshed every 30 min

Target snapshot

levocarnitine propionate (levocarnitine propionate). Levocarnitine propionate works by increasing the levels of levocarnitine in the body, which helps to transport fatty acids into the mitochondria for energy production.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
levocarnitine propionate TARGET	levocarnitine propionate		unknown	Carnitine Analog
Carnitor	LEVOCARNITINE	Leadiant Biosci Inc	marketed	Carnitine Analog [EPC]	Carnitine O-palmitoyltransferase 1, liver isoform	1985-01-01
CARNITINE	CARNITINE		marketed	Carnitine Analog [EPC]
L-carnitine	L-carnitine	Asan Medical Center	marketed	Carnitine Analog [EPC]
L-Ornithine	ORNITHINE		marketed	Carnitine Analog [EPC]	G-protein coupled receptor family C group 6 member A

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Carnitine Analog class)

· 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). levocarnitine propionate — Competitive Intelligence Brief. https://druglandscape.com/ci/levocarnitine-propionate. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing